Back to search

Article

Pharmacogenetics and the Blood-Brain Barrier: A Whirlwind Tour of Potential Clinical Utility

2024-07-22

Abstract excerpt

Genetic factors influence medication response (pharmacogenetics), affecting the pharmacody-namics and pharmacokinetics of many medicaments used in clinical care. The ability of medica-tions to cross the blood-brain barrier (BBB) represents a critical putative factor in the effectiveness and tolerability of various central nervous system (CNS) medications at a pharmacokinetic (dosing) level. Pharmacogenetics has th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c53ad22d-43dd-565e-a3ae-8a21879f68fc
DOI
10.20944/preprints202407.1682.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacogenetics and the Blood-Brain Barrier: A Whirlwind Tour of Potential Clinical UtilityDOI 10.20944/preprints202407.1682.v1
The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.Semantic proximity
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.Semantic proximity
Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive reviewSemantic proximity
Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.Semantic proximity
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant PharmacotherapySemantic proximity
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?Semantic proximity
Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparison.Semantic proximity
The association of ABCB1 gene polymorphism with clinical response to carbamazepine monotherapy in patients with epilepsy.Semantic proximity
Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.Semantic proximity
ABCB1 genotyping in the treatment of depression.Semantic proximity
[Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].Semantic proximity
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studiesSemantic proximity
Select a neighboring publication to make it the new centre.